lHeim_B

Tau6C phosphorylation.

AI Overview (Google's Gemini, March 26, 2026)

Yes, multiple phosphate (PO4) molecules can bind within the same functional regions or "pockets" of the tau protein, particularly in cases of hyperphosphorylation associated with Alzheimer’s disease.

Clustered Phosphorylation Sites: Tau is an intrinsically disordered protein (IDP) with about 85 potential phosphorylation sites. These sites are heavily clustered in the proline-rich region (residues 172-251) and the C-terminal tail (residues 368-441), which flank the microtubule-binding repeats. This high density means multiple phosphate groups often populate these regions simultaneously.
Binding Pocket Overlap: In the pathological, "hyperphosphorylated" state, the balance of kinases and phosphatases is disrupted, leading to the accumulation of many phosphate groups on a single tau molecule.
Specific Examples: Research shows that in Alzheimer’s diseased brains, hyperphosphorylated tau often has 5–9 phosphorylation sites modified, compared to only 2–3 in healthy adults.
Effect of Multiple Phosphates: The binding of multiple phosphates acts cumulatively. As more phosphate groups bind to tau, they remove the positive charge of the microtubule-binding region (MTBR), causing the tau protein to lose its affinity for microtubules, leading to aggregation.
Cooperative Binding: Phosphorylation at one site can sometimes prime or enhance phosphorylation at nearby sites within the same binding domain, facilitating the clustering of multiple phosphates.

In summary, the high concentration of potential sites in specific domains makes it likely that multiple phosphate groups reside in the same or closely positioned areas, directly causing the conformational changes that lead to pathology.

Order of binding	Receptor	Ligand	Affinity	Pocket ID	Residues that formed the binding pocket	Presence of SER, THR, TYR
1	Tau6C	PO4	-2.782	receptor_Tau6C_11	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
2	Tau6C	PO4	-2.724	receptor_Tau6C_3	LYS-660 LEU-661 ASP-662 PHE-663 ASP-665 ARG-666 VAL-667
3	Tau6C	PO4	-2.56	receptor_Tau6C_11	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
4	Tau6C	PO4	-2.484	receptor_Tau6C_11	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
5	Tau6C	PO4	-2.473	receptor_Tau6C_18	VAL-667 GLN-668 SER-669 GLY-672 LEU-674 ASP-675	SER-669
6	Tau6C	PO4	-2.454	receptor_Tau6C_11	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
7	Tau6C	PO4	-2.531	receptor_Tau6C_11	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
8	Tau6C	PO4	-2.73	receptor_Tau6C_11	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
9	Tau6C	PO4	-2.364	receptor_Tau6C_13	ILE-734 ASP-735 MET-736 VAL-737 ASP-738 SER-739 PRO-740 LEU-742	SER-739